Latest Commercialisation News

Livium Ltd has entered a binding term sheet with Iondrive Limited to collaborate on recycling end-of-life solar panels, lithium-ion battery black mass, and rare earth magnets using Iondrive’s innovative Deep Eutectic Solvent (DES) technology. This partnership aims to position both companies at the forefront of Australia’s emerging clean energy waste recycling market.

EMVision Medical Devices has raised $12 million through a placement backed by institutional investors, including strategic partner Keysight Technologies, and launched a Share Purchase Plan to raise up to $2 million from existing shareholders. The capital will support key clinical and regulatory milestones for its neurodiagnostic devices over the next two years.

EBR Systems has achieved a significant commercial milestone with its tenth US implant of the WiSE wireless cardiac pacing system, setting the stage for broader market adoption supported by new reimbursement schemes.

OD6 Metals has launched a metallurgical diamond core drilling program at its Splinter Rock Rare Earth Project, aiming to refine heap leach processing and produce high-quality rare earth samples for offtake talks.

Global Laser Enrichment, Silex’s exclusive licensee, has completed large-scale uranium enrichment testing, advancing the SILEX technology closer to commercial deployment in the US nuclear fuel market.

Advanced Health Intelligence has appointed Dylan Garnett as its new CEO, signaling a strategic pivot towards commercialisation and revenue growth. Garnett’s extensive background in healthcare, insurance, and digital health positions AHI for its next growth phase.

Xstate Resources has completed well pad construction for its Diona-1 well in Queensland’s Surat-Bowen Basin and is poised to begin drilling with a 51% interest in ATP 2077.

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.

First Graphene’s UK partner Vector Group has filed patents for novel fire-resistant materials enhanced with PureGRAPH graphene, showing 100% self-extinguishing performance and improved safety for construction.

Jatcorp has officially appointed Dr Xinpeng (Sean) Li as its CEO, locking in a three-year contract that underscores a strategic focus on sustainable growth and innovation.

Artrya Limited has completed the first tranche of its A$75 million placement, raising approximately A$60 million to advance its AI-driven coronary artery disease platform. Eligible shareholders can now participate in a Share Purchase Plan at the same price.

Cleo Diagnostics has received encouraging feedback from the U.S. FDA on its ovarian cancer pre-surgical triage test, reinforcing its clinical trial design and regulatory strategy ahead of a critical 510(k) submission.